Personalized GLP-1 Dosing

Personalized GLP-1 dosing refers to your licensed provider tailoring your starting dose and titration schedule within standard GLP-1 protocols, based on your individual tolerability and response. Your provider determines the appropriate dosing strategy based on your health profile. This is not self-directed dosing.

Patients who have experienced significant gastrointestinal side effects with standard doses, are sensitive to medication changes, have a lower baseline body weight (BMI closer to 27), prefer a more gradual introduction to GLP-1 therapy, or have medical conditions that warrant cautious dosing may ask about personalized protocols. Not all patients are candidates. Your licensed provider will assess your individual health profile, medication history, and treatment goals to determine if personalized dosing is clinically appropriate for you.

Standard GLP-1 dosing typically starts at a low weekly dose for semaglutide and increases on a structured schedule toward a target therapeutic level. Personalized dosing means your provider adjusts the pace and target of that titration based on your individual response and tolerability, rather than a fixed one-size-fits-all schedule. The goal is to find the dose that produces meaningful clinical benefits for you, as determined by your licensed provider.

GLP-1 receptor agonists are prescription medications that affect appetite, digestion, blood sugar, and gastrointestinal function. Dose selection and adjustment must be supervised by a licensed medical provider who reviews your complete health history, current medications, and response to therapy. Patients should never self-adjust dose, skip doses, or accelerate titration without provider guidance. Doing so can increase the risk of adverse effects and reduce the likelihood of achieving sustainable outcomes. All prescribing and dosing decisions are made by your independent licensed provider.

No. Personalized dosing is not a separate product. It is a provider-guided dosing strategy your licensed clinician may apply within standard GLP-1 programs, adjusting your starting dose and titration pace based on your individual tolerability and response. For current GLP-1 program pricing, see the semaglutide and tirzepatide program pages.

Eligibility is determined by an independent licensed medical provider based on your individual health profile. Generally, GLP-1 programs are appropriate for adults with a BMI of 30+ (obese), or 27+ (overweight) with at least one weight-related health condition. Personalized dosing may be considered for patients with lower baseline weight, medication sensitivity, or prior side effects. Not all patients qualify. Available nationwide in all 50 states. A valid patient-provider relationship must be established before any prescription is issued.

Clinical evidence suggests that GLP-1 receptor agonists can produce meaningful weight reduction across the dose range, though average results at lower doses may be less than those achieved at maximum therapeutic doses in clinical trials. The key benefit of personalized dosing is improved tolerability and adherence, which may support more sustainable outcomes than stopping therapy due to intolerable side effects at higher doses. Individual results vary significantly and are not guaranteed.

Common side effects of GLP-1 therapy include nausea, vomiting, diarrhea, constipation, abdominal cramping, bloating, fatigue, and headache. A gradual titration typically produces fewer and milder gastrointestinal side effects. However, all patients should be aware of the risk of gallbladder-related symptoms, pancreatitis, and thyroid C-cell tumors (contraindicated in patients with personal or family history of MTC or MEN 2). Report severe or persistent symptoms to your provider immediately. A full safety review is conducted before prescribing.

Never change your dose, skip doses, double doses, or stop medication without consulting your provider. Never share your medication with anyone else. Never combine GLP-1 therapy with other prescription weight loss medications or unregulated supplements without provider approval. Never pursue extreme diets, prolonged fasting, or intense exercise regimens without discussing them with your provider first. Never ignore persistent or severe side effects. Always follow your provider's prescribed plan.

If prescribed, your medication ships discreetly from a licensed compounding pharmacy directly to your address. Packaging is plain and unmarked with no external branding or medication labels visible. Shipping is included in your plan price. Refrigerated medications ship with cold-chain packaging. Your health data is encrypted end-to-end and handled in strict accordance with HIPAA privacy standards. Open Water Rx never sells your data.

Open Water Rx serves patients in all 50 states through telehealth. Some states require a brief synchronous video visit before a prescription can be issued. During your intake, our platform automatically identifies your state's specific requirements and guides you through any necessary steps. If a video visit is required, it is included in your program at no additional charge.

Yes. If you are currently on a standard GLP-1 program and experiencing side effects or feel the dose is too aggressive, your provider can discuss transitioning to a personalized dosing protocol. This typically involves a brief taper followed by re-initiation with a slower titration schedule, as directed by your provider. Any dosing change requires provider review and a new prescription. Contact our support team to discuss whether personalized dosing may be appropriate for your situation.